KNW
GILD icon

Kesler Norman & Wride’s Gilead Sciences GILD Stock Holding History

Kesler Norman & Wride’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$246K Buy
+1,950
New +$257K 0.04% 252

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Kesler Norman & Wride's GILD Position: Q2 2026 in Review

Kesler Norman & Wride opened a new position in Gilead Sciences (GILD) in Q2 2026: 1,950 shares worth $246K. The stake represents 0.04% of the portfolio and ranks #252 among its holdings.

2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Kesler Norman & Wride held 1,950 shares of Gilead Sciences worth $246K as of Q2 2026.
  • Gilead Sciences was a new Kesler Norman & Wride position in Q2 2026.
  • Gilead Sciences made up 0.04% of Kesler Norman & Wride's portfolio in Q2 2026, its #252 holding.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Kesler Norman & Wride's 13F filing for Q2 2026, filed 23 Jul 2026.